Pepstatin

Summary

Pepstatin A is a naturally occurring pentapeptide produced by various Streptomyces species. It is a potent inhibitor of aspartyl proteases and is widely used as a research tool in biochemistry and cell biology to inhibit lysosomal cathepsin D and related enzymes. It has been investigated for roles in neurodegeneration, cancer biology, and infectious disease but has not progressed to clinical approval due to poor bioavailability.

Mechanism of Action

Pepstatin is a competitive inhibitor of aspartyl (acid) proteases, including pepsin, renin, cathepsin D, and HIV protease. It contains a unique amino acid, statine [(3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid], which mimics the transition state of peptide bond hydrolysis at the active site of aspartyl proteases, thereby blocking substrate cleavage.

Routes of Administration

Goals & Uses

• HIV protease inhibitionAntiviral ResearchLow
• Anti-cancer (cathepsin D inhibition)Investigational TherapeuticLow
• Protease inhibitor cocktail componentResearch ToolHigh
• Neuroprotection in neurodegeneration modelsInvestigational TherapeuticLow
• Inhibition of cathepsin D in lysosomal researchResearch ToolHigh

Contraindications

• Clinical therapeutic use in humansRegulatoryHigh

Adverse Effects

• Poor oral/systemic bioavailabilityPharmacokineticCommon
• Non-selective aspartyl protease inhibitionPharmacodynamicCommon

Drug Interactions

• Renin inhibitorsModerate

Population Constraints

• Human clinical populationsGeneralAbsolute

Regulatory Status

• European UnionUnapprovedNo EMA approval; sold as laboratory chemical.
• United StatesUnapprovedAvailable only as a research reagent; no FDA approval or IND on record for therapeutic use.
• United KingdomUnapprovedNo MHRA approval; available as research reagent only.

Pepstatin A is not approved for clinical use in any major jurisdiction. It is sold as a laboratory reagent and protease inhibitor cocktail component. No approved therapeutic indication exists in the US, EU, or UK.

Evidence & Sources

No sources recorded yet.